NR1H4 and fatty liver disease: The FXR deficiency resulted in increased lipid content in the liver, serum cholesterol, and TGs in mice, whereas bile acid or synthetic agonist GW4064 reduced liver steatosis and plasma TGs by activating FXR [42, 43].